Common Contracts
4 similar Subscription Agreement contracts by Legend Biotech Corp, I-Mab
SUBSCRIPTION AGREEMENT dated as of April 19, 2023 by and between RA CAPITAL HEALTHCARE FUND, L.P. and LEGEND BIOTECH CORPORATIONSubscription Agreement • May 26th, 2023 • Legend Biotech Corp • Pharmaceutical preparations • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of April 19, 2023, by and between Legend Biotech Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”) and RA Capital Healthcare Fund, L.P., a Delaware limited partnership (the “Purchaser”).
SUBSCRIPTION AGREEMENT dated as of April 26, 2023 by and between LGN HOLDINGS LIMITED and LEGEND BIOTECH CORPORATIONSubscription Agreement • May 26th, 2023 • Legend Biotech Corp • Pharmaceutical preparations • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of April 26, 2023, by and between Legend Biotech Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”) and LGN Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Purchaser”).
SUBSCRIPTION AGREEMENT dated as of May 19, 2023 by and between LGN HOLDINGS LIMITED and LEGEND BIOTECH CORPORATIONSubscription Agreement • May 26th, 2023 • Legend Biotech Corp • Pharmaceutical preparations • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of May 19, 2023, by and between Legend Biotech Corporation, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”) and LGN Holdings Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Purchaser”).
SUBSCRIPTION AGREEMENT dated as of September 3, 2020 by and between [NAME OF INVESTOR] and I-MABSubscription Agreement • December 1st, 2020 • I-Mab • Pharmaceutical preparations • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of September 3, 2020, by and between I-Mab, an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), and [Name of Investor] (the “Purchaser”).
